跳至主要内容
临床试验/CTRI/2018/05/013948
CTRI/2018/05/013948尚未招募不适用

Therapeutical evaluation of Kaphapittahara karma of Katuki (Picrorhiza kurroa Royle ex Benth.) with special reference to Urdhwaga Amlapitta

Government Ayurved College and Hospital Vadodara1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年2月8日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Observations will be assessed on the basis of improvement in the signs & symptoms of the disease mentioned in Classical texts

研究概览

简要总结

The study is a Randomized, Parallel Group, Open Label, Active Controlled trial to evaluate the efficacy of Katuki Churna in two divided doses with Sarkara for 2 weeks to 20 patients under Group B while in Group A Comparator agent which is Yashtimadhu churna will be administered in three divided doses with water for 2 weeks to 20 patients. The Clinical Data obtained will be summarized at the end of the study and conclusion will be made after the statistical analysis of the data

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients between age group of 20-60 years.
  • Uncomplicated cases with classical signs and symptoms of Urdhwaga Amlapitta will be selected from the O.P.D. and I.P.D. sections.

排除标准

  • Patients having age less than 20 years and more than 60 years.
  • Patients diagnosed with heamatemesis, acute diarrhoea, intestinal T.B., gastric and peptic ulcer, perforation, Systemic disorders like Diabetes & Hypertension, haemorrhoid, carcinoma, cardiac disorders & serious condition of the patient.

结局指标

主要结局

Observations will be assessed on the basis of improvement in the signs & symptoms of the disease mentioned in Classical texts

时间窗: 2 weeks

次要结局

  • Assessment of the therapy will be done by preparing clinical proforma. The obtain data will be analyzed statistically(2 weeks)

研究者

发起方
Government Ayurved College and Hospital Vadodara
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验